China Molecular Blood Typing, Grouping and Infectious Disease NAT Market (2025-2031) | Competitive Landscape, Growth, Share, Industry, Analysis, Value, Size & Revenue, Outlook, Forecast, Segmentation, Trends, Companies

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 China Country Macro Economic Indicators

3.2 China Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume, 2021 & 2031F

3.3 China Molecular Blood Typing, Grouping and Infectious Disease NAT Market - Industry Life Cycle

3.4 China Molecular Blood Typing, Grouping and Infectious Disease NAT Market - Porter's Five Forces

3.5 China Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume Share, By Nature of Tests, 2021 & 2031F

3.6 China Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume Share, By Applicaions, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Rising prevalence of infectious diseases in China

4.2.2 Increasing awareness about the importance of blood typing and grouping

4.2.3 Technological advancements in molecular testing methods

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for molecular testing in China

4.3.2 Limited reimbursement policies for molecular blood typing and grouping

4.3.3 High initial setup costs for laboratories offering molecular testing services

6.1 China Molecular Blood Typing, Grouping and Infectious Disease NAT Market, By Nature of Tests

6.1.1 Overview and Analysis

6.1.2 China Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume, By Nature of Tests, 2021- 2031F

6.1.3 China Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume, By ABO, 2021- 2031F

6.1.4 China Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume, By Antibody Screening/Indirect Antiglobulin, 2021- 2031F

6.1.5 China Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume, By Antibody Panels, 2021- 2031F

6.1.6 China Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume, By Antigen Typing, 2021- 2031F

6.1.7 China Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume, By Antiglobulin, 2021- 2031F

6.1.8 China Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume, By Rh, 2021- 2031F

6.2 China Molecular Blood Typing, Grouping and Infectious Disease NAT Market, By Applicaions

6.2.1 Overview and Analysis

6.2.2 China Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume, By Hospitals, 2021- 2031F

6.2.3 China Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume, By Diagnostic Las, 2021- 2031F

6.2.4 China Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume, By Research Labs, 2021- 2031F

6.2.5 China Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenues & Volume, By Blood Banks, 2021- 2031F

7.1 China Molecular Blood Typing, Grouping and Infectious Disease NAT Market Export to Major Countries

7.2 China Molecular Blood Typing, Grouping and Infectious Disease NAT Market Imports from Major Countries

8.1 Adoption rate of molecular blood typing and grouping technologies in Chinese healthcare facilities

8.2 Number of research and development collaborations for developing advanced molecular testing solutions

8.3 Rate of integration of molecular testing into routine diagnostic procedures in China

8.4 Percentage increase in the number of trained professionals in molecular diagnostics

8.5 Level of government investment in promoting molecular testing technologies for infectious disease diagnosis

9.1 China Molecular Blood Typing, Grouping and Infectious Disease NAT Market Opportunity Assessment, By Nature of Tests, 2021 & 2031F

9.2 China Molecular Blood Typing, Grouping and Infectious Disease NAT Market Opportunity Assessment, By Applicaions, 2021 & 2031F

10.1 China Molecular Blood Typing, Grouping and Infectious Disease NAT Market Revenue Share, By Companies, 2024

10.2 China Molecular Blood Typing, Grouping and Infectious Disease NAT Market Competitive Benchmarking, By Operating and Technical Parameters